Peter Kolchinsky - Net Worth and Insider Trading
Peter Kolchinsky Net Worth
The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2026-08-13. Peter Kolchinsky is the Director, 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion. Peter Kolchinsky is the Director, 10% Owner of Forma Therapeutics Holdings Inc and owns about 9,011,651 shares of Forma Therapeutics Holdings Inc (FMTX) stock worth over $180 Million. Peter Kolchinsky is also the Director of Dicerna Pharmaceuticals Inc and owns about 0 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $0. Details can be seen in Peter Kolchinsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Kolchinsky has not made any transactions after 2020-06-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Kolchinsky
Peter Kolchinsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Kolchinsky owns 79 companies in total, including Vaxcyte Inc (PCVX) , Cardiff Oncology Inc (CRDF) , and PMV Pharmaceuticals Inc (PMVP) among others .
Click here to see the complete history of Peter Kolchinsky’s form 4 insider trades.
Insider Ownership Summary of Peter Kolchinsky
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PCVX | Vaxcyte Inc | 2020-06-16 | 10 percent owner |
| CRDF | Cardiff Oncology Inc | 2020-09-30 | 10 percent owner |
| PMVP | PMV Pharmaceuticals Inc | 2020-09-24 | 10 percent owner |
 | | 2020-09-16 | 10 percent owner |
| | 2019-11-08 | director & 10 percent owner |
| | 2020-05-05 | 10 percent owner |
| | 2020-08-18 | 10 percent owner |
| | 2017-08-10 | director & 10 percent owner |
| | 2020-07-23 | 10 percent owner |
| | 2020-07-23 | 10 percent owner |
| | 2020-07-21 | 10 percent owner |
| | 2020-07-09 | 10 percent owner |
| | 2020-07-07 | director & Chief Executive Officer |
| | 2019-10-16 | 10 percent owner |
| | 2020-06-25 | 10 percent owner |
| | 2020-03-03 | 10 percent owner |
| | 2020-06-23 | director & 10 percent owner |
| | 2020-04-02 | director & 10 percent owner |
| | 2019-10-25 | 10 percent owner |
| | 2020-03-11 | 10 percent owner |
| | 2020-03-13 | director & 10 percent owner |
| | 2020-02-14 | 10 percent owner |
| | 2020-01-23 | director & 10 percent owner |
| | 2019-12-02 | director |
| | 2020-12-03 | director & 10 percent owner |
| | 2018-10-23 | 10 percent owner |
| | 2018-09-26 | 10 percent owner |
| | 2018-06-22 | 10 percent owner |
| | 2016-11-21 | 10 percent owner |
| | 2017-05-16 | 10 percent owner |
| | 2015-10-07 | 10 percent owner |
| | 2014-09-29 | other: Former 10% Owner & See FN(5)(6) |
| | 2013-06-26 | 10 percent owner |
| | 2014-01-10 | other: Fmr 10% Owner - See Fn (1)-(5) |
| | 2010-02-26 | 10 percent owner |
| | 2008-10-29 | 10 percent owner |
| | 2008-07-10 | 10 percent owner |
| | 2007-08-08 | 10 percent owner |
| | 2021-08-03 | 10 percent owner |
| | 2021-06-30 | director & 10 percent owner |
| | 2020-12-07 | 10 percent owner |
| | 2021-09-14 | director & 10 percent owner |
| | 2020-11-22 | 10 percent owner |
| | 2020-12-10 | director & 10 percent owner |
| | 2020-08-06 | 10 percent owner |
| | 2021-08-09 | director & 10 percent owner |
| | 2021-04-29 | director & 10 percent owner |
| | 2021-07-28 | director & 10 percent owner |
| | 2021-06-29 | director & 10 percent owner |
| | 2020-07-07 | director & Chief Executive Officer |
| | 2021-02-04 | director & 10 percent owner |
| | 2021-06-10 | director & 10 percent owner |
| | 2021-03-17 | director & Chief Executive Officer |
| | 2021-07-22 | director |
| | 2022-05-05 | director & 10 percent owner |
| | 2021-09-14 | director & 10 percent owner |
| | 2022-03-24 | 10 percent owner |
| | 2022-08-16 | 10 percent owner |
| | 2022-11-08 | director |
| | 2022-11-09 | director & 10 percent owner |
| | 2022-11-08 | director |
| | 2020-03-11 | 10 percent owner |
| | 2023-02-09 | director & 10 percent owner |
| | 2023-07-05 | director |
| | 2024-10-24 | director & 10 percent owner |
| | 2024-04-24 | director & 10 percent owner |
| | 2024-11-13 | 10 percent owner |
| | 2024-03-27 | 10 percent owner |
| | 2021-06-29 | director & 10 percent owner |
| | 2024-03-21 | director & 10 percent owner |
| | 2024-07-18 | director & 10 percent owner |
| | 2024-09-12 | director & 10 percent owner |
| | 2025-02-06 | director & 10 percent owner |
| | 2025-11-05 | director & 10 percent owner |
| | 2026-02-05 | director & 10 percent owner |
| | 2026-02-17 | 10 percent owner |
| | 2026-06-09 | director |
| | 2026-04-21 | 10 percent owner |
| | 2026-04-30 | director & 10 percent owner |
Peter Kolchinsky Latest Holdings Summary
Peter Kolchinsky currently owns a total of 3 stocks. Among these stocks, Peter Kolchinsky owns 14,903,741 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $1.0 Billion and a weighting of 84.89%. Peter Kolchinsky owns 9,011,651 shares of Forma Therapeutics Holdings Inc (FMTX) as of June 23, 2020, with a value of $180 Million and a weighting of 15.11%. Peter Kolchinsky also owns 0 shares of Dicerna Pharmaceuticals Inc (DRNA) as of December 2, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Peter Kolchinsky
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| THOR | Synthorx Inc | 2018-12-11 | 14,903,741 | 67.99 | 1,013,305,351 |
| FMTX | Forma Therapeutics Holdings Inc | 2020-06-23 | 9,011,651 | 20.01 | 180,323,137 |
| DRNA | Dicerna Pharmaceuticals Inc | 2019-12-02 | 0 | 38.22 | 0 |
Holding Weightings of Peter Kolchinsky
Peter Kolchinsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Kolchinsky has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 4,545,455 shares on December 11, 2018, which cost Peter Kolchinsky around $50 Million.
According to the SEC Form 4 filings, Peter Kolchinsky has made a total of 0 transactions in Forma Therapeutics Holdings Inc (FMTX) over the past 5 years. The most-recent trade in Forma Therapeutics Holdings Inc is the acquisition of 4,000,000 shares on June 23, 2020, which cost Peter Kolchinsky around $80 Million.
According to the SEC Form 4 filings, Peter Kolchinsky has made a total of 0 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 643,876 shares on December 2, 2019, which brought Peter Kolchinsky around $16 Million.
Insider Trading History of Peter Kolchinsky
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Peter Kolchinsky Trading Performance
GuruFocus tracks the stock performance after each of Peter Kolchinsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Kolchinsky is 14.21%. GuruFocus also compares Peter Kolchinsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Kolchinsky within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Kolchinsky's insider trading performs compared to the benchmark.
Performance of Peter Kolchinsky
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.53 | | | | | |
| Relative Return to S&P 500(%) | -11.42 | | | | | |
Peter Kolchinsky Ownership Network
Ownership Network List of Peter Kolchinsky
Ownership Network Relation of Peter Kolchinsky
Peter Kolchinsky Owned Company Details
What does Vaxcyte Inc do?
Who are the key executives at Vaxcyte Inc?
Peter Kolchinsky is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include SVP Cml Mfg & Supply Chain Harpreet S. Dhaliwal , Chief Operating Officer Jim Wassil , and CFO & CBO Andrew Guggenhime .
Vaxcyte Inc (PCVX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 26,645 shares made by Jim Wassil , a net sale of 38,000 shares made by Andrew Guggenhime , and a net sale of 19,015 shares made by Elvia Cowan .
In summary, during the past 3 months, insiders sold 120,646 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 120,646 shares. During the past 18 months, 182,299 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 182,299 shares.
Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxcyte Inc Insider Transactions
- Download to Excel(.xlsx)
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Peter Kolchinsky is the 10 percent owner of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include director & Interim CEO Mani Mohindru , Chief Operating Officer Ajay Aggarwal , and Chief Financial Officer Joshua B Muntner .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 1,007,285 shares made by Gary W Pace , and a net purchase of 59,067 shares made by Mani Mohindru .
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 776,352 shares, with a net purchase of 776,352 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 1,066,352 shares were bought by its insiders, resulting in a net purchase of 1,066,352 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
- Download to Excel(.xlsx)
What does PMV Pharmaceuticals Inc do?
Who are the key executives at PMV Pharmaceuticals Inc?
Peter Kolchinsky is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , director & President and CEO David Henry Mack , and SVP & Regulatory Affairs and QA Deepika Jalota .
PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 1,500,000 shares made by Orbimed Advisors Llc , a net sale of 58,411 shares made by David Henry Mack , and a net sale of 33,065 shares made by Deepika Jalota .
In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,642,876 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,642,876 shares.
PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.
PMV Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , director & 10 percent owner Jason P Rhodes , and Chief Financial Officer Erick Lucera .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 1,876,050 shares made by Dirk Kersten , a net purchase of 77,851 shares made by John Cox , and a net sale of 3,102,817 shares made by Jason P Rhodes .
In summary, during the past 3 months, insiders sold 2,165,760 shares of Dyne Therapeutics Inc (DYN) in total and bought 9,000 shares, with a net sale of 2,156,760 shares. During the past 18 months, 5,031,129 shares of Dyne Therapeutics Inc (DYN) were sold and 116,000 shares were bought by its insiders, resulting in a net sale of 4,915,129 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does 89bio Inc do?
Who are the key executives at 89bio Inc?
Peter Kolchinsky is the director & 10 percent owner of 89bio Inc. Other key executives at 89bio Inc include See Remarks Quoc Le-nguyen , director & 10 percent owner Ra Capital Healthcare Fund Lp , and director & Chief Executive Officer Rohan Palekar .
89bio Inc (ETNB) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in 89bio Inc (ETNB). Other recent insider transactions involving 89bio Inc (ETNB) include a net sale of 25,790 shares made by Quoc Le-nguyen ,
In summary, during the past 3 months, insiders sold 0 shares of 89bio Inc (ETNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,790 shares of 89bio Inc (ETNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,790 shares.
89bio Inc (ETNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
89bio Inc Insider Transactions
- Download to Excel(.xlsx)
What does TG Therapeutics Inc do?
Who are the key executives at TG Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .
TG Therapeutics Inc (TGTX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 15,000 shares made by Yann Echelard , and a net sale of 20,852 shares made by Sagar Lonial .
In summary, during the past 3 months, insiders sold 0 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,852 shares of TG Therapeutics Inc (TGTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,852 shares.
TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TG Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Peter Kolchinsky is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inhibrx Inc (INBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
- Download to Excel(.xlsx)
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Peter Kolchinsky is the director & 10 percent owner of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include Chief Scientific Officer Erik Ingelsson , Chief Medical Officer Christopher I Wright , and 10 percent owner Ra Capital Healthcare Fund Lp .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 485,483 shares made by Chris Francis , a net sale of 396,856 shares made by Paul Bolno , and a net sale of 156,345 shares made by Aik Na Tan .
In summary, during the past 3 months, insiders sold 0 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,572,253 shares of WAVE Life Sciences Ltd (WVE) were sold and 10,243,496 shares were bought by its insiders, resulting in a net purchase of 8,671,243 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
- Download to Excel(.xlsx)
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Peter Kolchinsky is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net sale of 8,819 shares made by Douglas A Treco ,
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,819 shares of Inozyme Pharma Inc (INZY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,819 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
- Download to Excel(.xlsx)
What does ITeos Therapeutics Inc do?
Who are the key executives at ITeos Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include director & Chief Executive Officer Michel Detheux , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Bioventures 2018, L.p. .
ITeos Therapeutics Inc (ITOS) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net sale of 261,412 shares made by Michel Detheux , a net purchase of 4,958,978 shares made by Ecor1 Capital, Llc , and a net sale of 1,031,931 shares made by Ansbert Gadicke .
In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,668,407 shares of ITeos Therapeutics Inc (ITOS) were sold and 4,958,978 shares were bought by its insiders, resulting in a net purchase of 2,290,571 shares.
ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
ITeos Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Peter Kolchinsky is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include director & See Remarks Paul J Hastings , Chief Business Officer Nadir Mahmood , and See Remarks Shawn Marshall Rose .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 29,612 shares made by Paul J Hastings , and a net sale of 5,649 shares made by Nadir Mahmood .
In summary, during the past 3 months, insiders sold 1,776 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 1,776 shares. During the past 18 months, 35,261 shares of Nkarta Inc (NKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,261 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xlsx)
What does Therapeutics Acquisition Corp do?
Who are the key executives at Therapeutics Acquisition Corp?
Peter Kolchinsky is the director & Chief Executive Officer of Therapeutics Acquisition Corp. Other key executives at Therapeutics Acquisition Corp include 10 percent owner Therapeutics Acquisition Holdings Llc , and director & Chief Financial Officer Matthew Hammond .
Therapeutics Acquisition Corp (RACA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Therapeutics Acquisition Corp (RACA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Therapeutics Acquisition Corp (RACA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Therapeutics Acquisition Corp (RACA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Therapeutics Acquisition Corp Insider Transactions
- Download to Excel(.xlsx)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Peter Kolchinsky is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , CFO and Treasurer Hunter C Smith , and Chief Human Resources Officer Pamela J. Cramer .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 82,462 shares made by Pamela J. Cramer , a net sale of 61,150 shares made by Joseph Shulman , and a net sale of 117,476 shares made by Hunter C Smith .
In summary, during the past 3 months, insiders sold 41,643 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 41,643 shares. During the past 18 months, 538,506 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 538,506 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Peter Kolchinsky is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
- Download to Excel(.xlsx)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Peter Kolchinsky is the 10 percent owner of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 145,568 shares made by Dan Paterson , a net sale of 24,659 shares made by Daniel Calkins , and a net sale of 2,366 shares made by Brian M Stuglik .
In summary, during the past 3 months, insiders sold 26,262 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 26,262 shares. During the past 18 months, 196,858 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,858 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xlsx)
What does Forma Therapeutics Holdings Inc do?
Who are the key executives at Forma Therapeutics Holdings Inc?
Peter Kolchinsky is the director & 10 percent owner of Forma Therapeutics Holdings Inc. Other key executives at Forma Therapeutics Holdings Inc include EVP & Research & Development Agustin Melian , SVP & Chief Scientific Officer David N Cook , and SVP & Chief Financial Officer Todd Shegog .
Forma Therapeutics Holdings Inc (FMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc (FMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc (FMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Forma Therapeutics Holdings Inc (FMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Forma Therapeutics Holdings Inc Insider Transactions
- Download to Excel(.xlsx)
What does Ra Pharmaceuticals Inc do?
Who are the key executives at Ra Pharmaceuticals Inc?
Peter Kolchinsky is the director & 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Scott D Sandell .
Ra Pharmaceuticals Inc (RARX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ra Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Phathom Pharmaceuticals Inc do?
Who are the key executives at Phathom Pharmaceuticals Inc?
Peter Kolchinsky is the 10 percent owner of Phathom Pharmaceuticals Inc. Other key executives at Phathom Pharmaceuticals Inc include Principal Accounting Officer Robert Charles Breedlove , Chief Financial & Bus. Officer Sanjeev Narula , and Chief Legal Off. & Corp. Sec. Anne Marie Cook .
Phathom Pharmaceuticals Inc (PHAT) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net purchase of 59,403 shares made by James N Topper , a net sale of 2,677 shares made by Robert Charles Breedlove , and a net purchase of 20,000 shares made by Asit Parikh .
In summary, during the past 3 months, insiders sold 0 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,355 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 79,403 shares were bought by its insiders, resulting in a net purchase of 73,048 shares.
Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Phathom Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Imara Inc do?
Who are the key executives at Imara Inc?
Peter Kolchinsky is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .
Imara Inc (IMRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Imara Inc Insider Transactions
- Download to Excel(.xlsx)
What does Kala Bio Inc do?
Who are the key executives at Kala Bio Inc?
Peter Kolchinsky is the director & 10 percent owner of Kala Bio Inc. Other key executives at Kala Bio Inc include director & Chief Executive Officer Avraham Minkowitz , 10 percent owner Oxford Finance Llc , and director & Chief Executive Officer David E. Lazar .
Kala Bio Inc (KALA) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 189,853 shares made by Mark T Iwicki , a net sale of 55,686 shares made by Romulus K Brazzell , and a net sale of 55,216 shares made by Todd Bazemore .
In summary, during the past 3 months, insiders sold 0 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,938 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,938 shares.
Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kala Bio Inc Insider Transactions
- Download to Excel(.xlsx)
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Peter Kolchinsky is the 10 percent owner of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Synthorx Inc do?
Who are the key executives at Synthorx Inc?
Peter Kolchinsky is the director & 10 percent owner of Synthorx Inc. Other key executives at Synthorx Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Ra Capital Management, L.p. , and director & 10 percent owner Peter A. Thompson .
Synthorx Inc (THOR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Synthorx Inc (THOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synthorx Inc (THOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Synthorx Inc (THOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synthorx Inc Insider Transactions
- Download to Excel(.xlsx)
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Peter Kolchinsky is the director of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Peter Kolchinsky is the director & 10 percent owner of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Peter Kolchinsky is the 10 percent owner of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Peter Kolchinsky is the 10 percent owner of Arvinas Inc. Other key executives at Arvinas Inc include Chief Financial Officer Andrew Saik , Chief Scientific Officer Angela M Cacace , and director & President and CEO Randy Teel .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 27,224 shares made by Angela M Cacace , a net sale of 5,487 shares made by David K Loomis , and a net sale of 31,886 shares made by Noah Berkowitz .
In summary, during the past 3 months, insiders sold 10,481 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 10,481 shares. During the past 18 months, 188,976 shares of Arvinas Inc (ARVN) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 138,976 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
- Download to Excel(.xlsx)
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Senior Vice President & Finance Franco Valle , and Chief Business Officer Cameron Turtle .
Eidos Therapeutics Inc (EIDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc (EIDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc (EIDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc (EIDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Peter Kolchinsky is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Development Officer Christopher Yea , Chief Medical Officer Paul K. Audhya , and Chief Commercial Officer Nicole Sweeny .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net sale of 159,407 shares made by Benjamin L Palleiko , a net sale of 100,279 shares made by Christopher Yea , and a net sale of 44,877 shares made by Paul K. Audhya .
In summary, during the past 3 months, insiders sold 62,082 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 62,082 shares. During the past 18 months, 545,127 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 520,127 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include 10 percent owner Braden Michael Leonard , Chief Scientific Officer Roland Wilhelm Kolbeck , and Chief Medical Officer Jesse Wayne Hall .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 300,000 shares made by Braden Michael Leonard ,
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,000 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Achillion Pharmaceuticals Inc do?
Who are the key executives at Achillion Pharmaceuticals Inc?
Peter Kolchinsky is the other: Former 10% Owner & See FN(5)(6) of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .
Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achillion Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include Head of Research & Technology Gregory D Davis , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and Principal Accounting Officer Nikunj Jain .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 345,942 shares made by Nathalie Dubois-stringfellow , and a net sale of 69,827 shares made by Gregory D Davis .
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 415,769 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 415,769 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Derma Sciences Inc do?
Who are the key executives at Derma Sciences Inc?
Peter Kolchinsky is the other: Fmr 10% Owner - See Fn (1)-(5) of Derma Sciences Inc. Other key executives at Derma Sciences Inc include director & other: Executive Chairman Stephen T Wills , other: Former Director Bruce F Wesson , and other: Former Director Amy S Paul .
Derma Sciences Inc (DSCI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Derma Sciences Inc (DSCI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Derma Sciences Inc (DSCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Derma Sciences Inc (DSCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Derma Sciences Inc Insider Transactions
- Download to Excel(.xlsx)
What does BioSpecifics Technologies Corp do?
Who are the key executives at BioSpecifics Technologies Corp?
Peter Kolchinsky is the 10 percent owner of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .
BioSpecifics Technologies Corp (BSTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioSpecifics Technologies Corp Insider Transactions
- Download to Excel(.xlsx)
What does Aradigm Corp do?
Who are the key executives at Aradigm Corp?
Peter Kolchinsky is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner First Eagle Value In Biotechnology Master Fund, Ltd. .
Aradigm Corp (ARDMQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aradigm Corp Insider Transactions
- Download to Excel(.xlsx)
What does Sequenom Inc do?
Who are the key executives at Sequenom Inc?
Peter Kolchinsky is the 10 percent owner of Sequenom Inc. Other key executives at Sequenom Inc include director & EVP and Treasurer Glenn A Eisenberg , director & Chairman & President & Sec Eberts F Samuel Iii , and Sr VP & GC & Secretary Jeffrey D Linton .
Sequenom Inc (SQNM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sequenom Inc (SQNM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sequenom Inc (SQNM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sequenom Inc (SQNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sequenom Inc Insider Transactions
- Download to Excel(.xlsx)
What does Curis Inc do?
Who are the key executives at Curis Inc?
Peter Kolchinsky is the 10 percent owner of Curis Inc. Other key executives at Curis Inc include CMO Ahmed Md Hamdy , CDO Jonathan B. Zung , and CFO Diantha Duvall .
Curis Inc (CRIS) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Curis Inc (CRIS). Other recent insider transactions involving Curis Inc (CRIS) include a net purchase of 10,000 shares made by Kenneth I Kaitin ,
In summary, during the past 3 months, insiders sold 0 shares of Curis Inc (CRIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc (CRIS) were sold and 500 shares were bought by its insiders, resulting in a net purchase of 500 shares.
Curis Inc (CRIS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Curis Inc Insider Transactions
- Download to Excel(.xlsx)
What does RxSight Inc do?
Who are the key executives at RxSight Inc?
Peter Kolchinsky is the 10 percent owner of RxSight Inc. Other key executives at RxSight Inc include Chief Financial Officer Mark Wilterding , Chief Customer Officer Scott Gaines , and Chief Operating Officer Ilya Goldshleger .
RxSight Inc (RXST) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in RxSight Inc (RXST). Other recent insider transactions involving RxSight Inc (RXST) include a net sale of 7,000 shares made by Tamara Fountain ,
In summary, during the past 3 months, insiders sold 0 shares of RxSight Inc (RXST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,000 shares of RxSight Inc (RXST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,000 shares.
RxSight Inc (RXST)'s detailed insider trading history can be found in Insider Trading Tracker table.
RxSight Inc Insider Transactions
- Download to Excel(.xlsx)
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Peter Kolchinsky is the director & 10 percent owner of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , Chief Financial Officer Matt Zuga , and director & President and CEO Daniel Joseph Oconnell .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net sale of 115,513 shares made by Derek M Meisner , a net sale of 86,013 shares made by Daniel Joseph Oconnell , and a net sale of 25,953 shares made by Matt Zuga .
In summary, during the past 3 months, insiders sold 38,700 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 38,700 shares. During the past 18 months, 305,128 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 305,128 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc , Chief Legal Officer Jennifer Tousignant , and Chief Medical Officer Radhika Tripuraneni .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,631,015 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net sale of 2,272 shares made by Jennifer Tousignant .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,272 shares of Viridian Therapeutics Inc (VRDN) were sold and 1,631,015 shares were bought by its insiders, resulting in a net purchase of 1,628,743 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does DICE Therapeutics Inc do?
Who are the key executives at DICE Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of DICE Therapeutics Inc. Other key executives at DICE Therapeutics Inc include 10 percent owner Northpond Ventures Gp, Llc , CSO John R. Jacobsen , and director & CEO Kevin Judice .
DICE Therapeutics Inc (DICE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DICE Therapeutics Inc (DICE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.
DICE Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
Peter Kolchinsky is the 10 percent owner of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , Chief Commercial Officer Christine Coyne , and director & President & CEO Fishman Corey N. .
Iterum Therapeutics PLC (ITRMF) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Iterum Therapeutics PLC (ITRMF). Other recent insider transactions involving Iterum Therapeutics PLC (ITRMF) include a net purchase of 21,000 shares made by Michael W. Dunne ,
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRMF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRMF) were sold and 21,000 shares were bought by its insiders, resulting in a net purchase of 21,000 shares.
Iterum Therapeutics PLC (ITRMF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
- Download to Excel(.xlsx)
What does Solid Biosciences Inc do?
Who are the key executives at Solid Biosciences Inc?
Peter Kolchinsky is the director & 10 percent owner of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include See Remarks David T Howton , Chief Technology Officer Paul Herzich , and Chief Regulatory Officer Jessie Hanrahan .
Solid Biosciences Inc (SLDB) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 16,096 shares made by Ilan Ganot , a net sale of 167,988 shares made by Alexander Cumbo , and a net sale of 55,892 shares made by Kevin Tan .
In summary, during the past 3 months, insiders sold 0 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 420,673 shares of Solid Biosciences Inc (SLDB) were sold and 6,254,405 shares were bought by its insiders, resulting in a net purchase of 5,833,732 shares.
Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Solid Biosciences Inc Insider Transactions
- Download to Excel(.xlsx)
What does Orchard Therapeutics PLC do?
Who are the key executives at Orchard Therapeutics PLC?
Peter Kolchinsky is the 10 percent owner of Orchard Therapeutics PLC. Other key executives at Orchard Therapeutics PLC include director & See Remarks Bobby Gaspar , 10 percent owner & other: See Remark 1 Fmr Llc , and 10 percent owner Ra Capital Healthcare Fund Lp .
Orchard Therapeutics PLC (ORTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Orchard Therapeutics PLC Insider Transactions
- Download to Excel(.xlsx)
What does Climb Bio Inc do?
Who are the key executives at Climb Bio Inc?
Peter Kolchinsky is the director & 10 percent owner of Climb Bio Inc. Other key executives at Climb Bio Inc include director & President and CEO Aoife Brennan , director & 10 percent owner Ra Capital Healthcare Fund Lp , and Chief Financial Officer Susan Altschuller .
Climb Bio Inc (CLYM) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Climb Bio Inc (CLYM). Other recent insider transactions involving Climb Bio Inc (CLYM) include a net purchase of 321,672 shares made by Ra Capital Healthcare Fund Lp , a net sale of 150,000 shares made by Stephen Basil Thomas , and a net sale of 51,520 shares made by Aoife Brennan .
In summary, during the past 3 months, insiders sold 30,902 shares of Climb Bio Inc (CLYM) in total and bought 0 shares, with a net sale of 30,902 shares. During the past 18 months, 203,961 shares of Climb Bio Inc (CLYM) were sold and 321,672 shares were bought by its insiders, resulting in a net purchase of 117,711 shares.
Climb Bio Inc (CLYM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Climb Bio Inc Insider Transactions
- Download to Excel(.xlsx)
What does Werewolf Therapeutics Inc do?
Who are the key executives at Werewolf Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , VP of Finance & Corp. Contr. Michael J. Urban , and 10 percent owner Mpm Bioventures 2014, L.p. .
Werewolf Therapeutics Inc (HOWL) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net sale of 4,220,911 shares made by Luke Evnin , a net sale of 1,938,945 shares made by Mpm Oncology Innovations Fund Lp , and a net sale of 1,641,479 shares made by Mpm Bioventures 2014, L.p. .
In summary, during the past 3 months, insiders sold 2,670,469 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 2,670,469 shares. During the past 18 months, 9,910,475 shares of Werewolf Therapeutics Inc (HOWL) were sold and 536,426 shares were bought by its insiders, resulting in a net sale of 9,374,049 shares.
Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Werewolf Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Icosavax Inc do?
Who are the key executives at Icosavax Inc?
Peter Kolchinsky is the director & 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Financial Officer Thomas Joseph Russo , and Chief Medical Officer Niranjan Kanesa-thasan .
Icosavax Inc (ICVX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Icosavax Inc Insider Transactions
- Download to Excel(.xlsx)
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , See Remarks George A Eldridge , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Peter Kolchinsky is the director & Chief Executive Officer of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xlsx)
What does Vor Biopharma Inc do?
Who are the key executives at Vor Biopharma Inc?
Peter Kolchinsky is the director & 10 percent owner of Vor Biopharma Inc. Other key executives at Vor Biopharma Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Medical Officer Jeremy Brett Sokolove , and 10 percent owner Tcg Crossover Gp Iii, Llc .
Vor Biopharma Inc (VOR) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Vor Biopharma Inc (VOR). Other recent insider transactions involving Vor Biopharma Inc (VOR) include a net sale of 6,665,043 shares made by Reprogrammed Interchange Llc , and a net sale of 4,205,765 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 213 shares of Vor Biopharma Inc (VOR) in total and bought 0 shares, with a net sale of 213 shares. During the past 18 months, 4,987,561 shares of Vor Biopharma Inc (VOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,987,561 shares.
Vor Biopharma Inc (VOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vor Biopharma Inc Insider Transactions
- Download to Excel(.xlsx)
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include Chief Corp. & Bus. Dev. Ofcr Janeen Noel Doyle , Vice President & Accounting Maria Dobek , and Chief Medical Officer William Go .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 35,211 shares made by Andrew Hollman Meyer , a net sale of 3,500 shares made by Maria Dobek , and a net purchase of 824,041 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 4,059 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 4,059 shares. During the past 18 months, 58,462 shares of Janux Therapeutics Inc (JANX) were sold and 824,041 shares were bought by its insiders, resulting in a net purchase of 765,579 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Research Alliance Corp II do?
Who are the key executives at Research Alliance Corp II?
Peter Kolchinsky is the director & Chief Executive Officer of Research Alliance Corp II. Other key executives at Research Alliance Corp II include 10 percent owner Saba Capital Management, L.p. , 10 percent owner Boaz Weinstein , and director & Chief Investment Officer Matthew Hammond .
Research Alliance Corp II (RACB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Research Alliance Corp II (RACB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Research Alliance Corp II (RACB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Research Alliance Corp II (RACB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Research Alliance Corp II Insider Transactions
- Download to Excel(.xlsx)
What does Cytek Biosciences Inc do?
Who are the key executives at Cytek Biosciences Inc?
Peter Kolchinsky is the director of Cytek Biosciences Inc. Other key executives at Cytek Biosciences Inc include Chief Legal Officer & Secretary Ilan Feuchtwang , director & Chief Technology Officer Ming Yan , and Chief Financial Officer William D. Mccombe .
Cytek Biosciences Inc (CTKB) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Cytek Biosciences Inc (CTKB). Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net purchase of 35,000 shares made by William D. Mccombe ,
In summary, during the past 3 months, insiders sold 0 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cytek Biosciences Inc (CTKB) were sold and 35,000 shares were bought by its insiders, resulting in a net purchase of 35,000 shares.
Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytek Biosciences Inc Insider Transactions
- Download to Excel(.xlsx)
What does PepGen Inc do?
Who are the key executives at PepGen Inc?
Peter Kolchinsky is the director & 10 percent owner of PepGen Inc. Other key executives at PepGen Inc include Chief Technical Officer Kasra Kasraian , EVP & Head of R&D Paul Streck , and director & President and CEO James G Mcarthur .
PepGen Inc (PEPG) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net purchase of 46,225 shares made by James G Mcarthur , a net purchase of 6,496 shares made by Paul Streck , and a net sale of 3,611 shares made by Noel Donnelly .
In summary, during the past 3 months, insiders sold 1,233 shares of PepGen Inc (PEPG) in total and bought 0 shares, with a net sale of 1,233 shares. During the past 18 months, 13,430 shares of PepGen Inc (PEPG) were sold and 9,634,875 shares were bought by its insiders, resulting in a net purchase of 9,621,445 shares.
PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.
PepGen Inc Insider Transactions
- Download to Excel(.xlsx)
What does Tyra Biosciences Inc do?
Who are the key executives at Tyra Biosciences Inc?
Peter Kolchinsky is the director & 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include Vice President & Finance (PAO) Yuliya Rueb , Chief Operating Officer Daniel Bensen , and director & 10 percent owner Robert J More .
Tyra Biosciences Inc (TYRA) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 281,000 shares made by Daniel Bensen , a net purchase of 1,561,335 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 75,687 shares made by Gilla Kaplan .
In summary, during the past 3 months, insiders sold 0 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 613,558 shares of Tyra Biosciences Inc (TYRA) were sold and 1,561,335 shares were bought by its insiders, resulting in a net purchase of 947,777 shares.
Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyra Biosciences Inc Insider Transactions
- Download to Excel(.xlsx)
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include See Remarks Joshua M Eizen , Principal Accounting Officer Sarah Joanne Williams , and Chief Strategy Officer Stephen David Prior .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 33,618 shares made by Joshua M Eizen , a net sale of 2,732,000 shares made by Braden Michael Leonard , and a net sale of 7,227 shares made by Stephen David Prior .
In summary, during the past 3 months, insiders sold 6,210 shares of AN2 Therapeutics Inc (ANTX) in total and bought 0 shares, with a net sale of 6,210 shares. During the past 18 months, 2,791,495 shares of AN2 Therapeutics Inc (ANTX) were sold and 18,610 shares were bought by its insiders, resulting in a net sale of 2,772,885 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include 10 percent owner Kevin C Tang , 10 percent owner Tang Capital Management Llc , and director & President & CEO Robert J Gould .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 60,000 shares made by Robert J Gould , a net purchase of 417,562 shares made by Kevin C Tang , and a net sale of 4,175,139 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 18,000 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 417,562 shares, with a net purchase of 399,562 shares. During the past 18 months, 4,257,089 shares of Fulcrum Therapeutics Inc (FULC) were sold and 417,562 shares were bought by its insiders, resulting in a net sale of 3,839,527 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Peter Kolchinsky is the director of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: * Director by deputization Deerfield Management Co .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Acrivon Therapeutics Inc do?
Who are the key executives at Acrivon Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Acrivon Therapeutics Inc. Other key executives at Acrivon Therapeutics Inc include Chief Financial Officer Adam D. Levy , Chief Legal Officer Mary Miller , and director & President and CEO Peter Blume-jensen .
Acrivon Therapeutics Inc (ACRV) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net sale of 2,256,719 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 7,690 shares made by Adam D. Levy , and a net purchase of 49,000 shares made by Peter Blume-jensen .
In summary, during the past 3 months, insiders sold 1,715 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 1,715 shares. During the past 18 months, 2,258,434 shares of Acrivon Therapeutics Inc (ACRV) were sold and 67,832 shares were bought by its insiders, resulting in a net sale of 2,190,602 shares.
Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acrivon Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Peter Kolchinsky is the director of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include Chief Commercial Officer Eric Karas , Chief Legal Officer Alexander A Fitzpatrick , and President Donn Casale .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 65,000 shares made by Eric Karas , a net sale of 106,324 shares made by Alexander A Fitzpatrick , and a net sale of 100,002 shares made by Laura Shawver .
In summary, during the past 3 months, insiders sold 28,355 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 28,355 shares. During the past 18 months, 1,482,183 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,482,183 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xlsx)
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Financial Officer Benjamin Hohl , director & 10 percent owner Orbimed Advisors Llc , and director & Chief Scientific Officer Joseph P Lyssikatos .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 275,000 shares made by Joseph P Lyssikatos , a net sale of 112,500 shares made by Samuel Kintz , and a net sale of 53,036 shares made by Benjamin Hohl .
In summary, during the past 3 months, insiders sold 1,347,362 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 1,347,362 shares. During the past 18 months, 2,042,208 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,042,208 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Mineralys Therapeutics Inc do?
Who are the key executives at Mineralys Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include Chief Medical Officer David Malcom Rodman , Chief Commercial Officer Eric Warren , and director & Chief Executive Officer Jon Congleton .
Mineralys Therapeutics Inc (MLYS) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Mineralys Therapeutics Inc (MLYS). Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 563,054 shares made by David Malcom Rodman , a net sale of 438,969 shares made by Jon Congleton , and a net sale of 236,233 shares made by Adam Scott Levy .
In summary, during the past 3 months, insiders sold 248,836 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 248,836 shares. During the past 18 months, 2,405,493 shares of Mineralys Therapeutics Inc (MLYS) were sold and 4,889,260 shares were bought by its insiders, resulting in a net purchase of 2,483,767 shares.
Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mineralys Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Peter Kolchinsky is the director of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , 10 percent owner Versant Venture Capital Vi, L.p. , and director & See Remarks David M. Epstein .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V ,
In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,784,292 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,784,292 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Septerna Inc do?
Who are the key executives at Septerna Inc?
Peter Kolchinsky is the director & 10 percent owner of Septerna Inc. Other key executives at Septerna Inc include SVP & Drug Discovery Daniel D. Long , Chief Operating Officer Elizabeth Bhatt , and Chief People Officer Samira Shaikhly .
Septerna Inc (SEPN) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Septerna Inc (SEPN). Other recent insider transactions involving Septerna Inc (SEPN) include a net sale of 96,614 shares made by Samira Shaikhly , a net sale of 25,168 shares made by Daniel D. Long , and a net sale of 12,000 shares made by Elizabeth Bhatt .
In summary, during the past 3 months, insiders sold 51,828 shares of Septerna Inc (SEPN) in total and bought 0 shares, with a net sale of 51,828 shares. During the past 18 months, 133,782 shares of Septerna Inc (SEPN) were sold and 1,216,203 shares were bought by its insiders, resulting in a net purchase of 1,082,421 shares.
Septerna Inc (SEPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Septerna Inc Insider Transactions
- Download to Excel(.xlsx)
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include CHIEF LEGAL OFFICER Shane Ward , Chief Medical Officer Nicole Negar Davarpanah , and Chief Scientific Officer Leslie Tari .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 11,623 shares made by Shane Ward , a net purchase of 2,272,727 shares made by Ra Capital Healthcare Fund Lp , and a net purchase of 3,320 shares made by Chrysa Mineo .
In summary, during the past 3 months, insiders sold 0 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,870 shares of Cidara Therapeutics Inc (CDTX) were sold and 2,276,047 shares were bought by its insiders, resulting in a net purchase of 2,262,177 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include director & Chief Executive Officer David Kirn , Chief Legal and HR Officer Scott Bizily , and VP & Finance and Controller Ashoo Gupta .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 28,774 shares made by Scott Bizily , a net sale of 214,258 shares made by David Kirn , and a net sale of 779 shares made by Ashoo Gupta .
In summary, during the past 3 months, insiders sold 230,634 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 230,634 shares. During the past 18 months, 243,811 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,811 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Boundless Bio Inc do?
Who are the key executives at Boundless Bio Inc?
Peter Kolchinsky is the 10 percent owner of Boundless Bio Inc. Other key executives at Boundless Bio Inc include 10 percent owner Kevin C Tang , 10 percent owner Arch Venture Fund Ix Overage, L.p. , and 10 percent owner Keith Crandell .
Boundless Bio Inc (BOLD) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Boundless Bio Inc (BOLD). Other recent insider transactions involving Boundless Bio Inc (BOLD) include a net purchase of 611,423 shares made by Kevin C Tang , a net sale of 16,000 shares made by Keith Crandell , and a net sale of 16,000 shares made by Arch Venture Fund Ix Overage, L.p. .
In summary, during the past 3 months, insiders sold 32,000 shares of Boundless Bio Inc (BOLD) in total and bought 611,423 shares, with a net purchase of 579,423 shares. During the past 18 months, 32,000 shares of Boundless Bio Inc (BOLD) were sold and 611,423 shares were bought by its insiders, resulting in a net purchase of 579,423 shares.
Boundless Bio Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Boundless Bio Inc Insider Transactions
- Download to Excel(.xlsx)
What does Jade Biosciences Inc do?
Who are the key executives at Jade Biosciences Inc?
Peter Kolchinsky is the director & 10 percent owner of Jade Biosciences Inc. Other key executives at Jade Biosciences Inc include director & 10 percent owner Fairmount Healthcare Co-invest Iv L.p. , Chief Financial Officer Bradford D. Dahms , and See Remarks Andrew James King .
Jade Biosciences Inc (JBIO) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Jade Biosciences Inc (JBIO). Other recent insider transactions involving Jade Biosciences Inc (JBIO) include a net purchase of 6,000 shares made by Tom Frohlich ,
In summary, during the past 3 months, insiders sold 0 shares of Jade Biosciences Inc (JBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jade Biosciences Inc (JBIO) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.
Jade Biosciences Inc (JBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jade Biosciences Inc Insider Transactions
- Download to Excel(.xlsx)
What does LENZ Therapeutics Inc do?
Who are the key executives at LENZ Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of LENZ Therapeutics Inc. Other key executives at LENZ Therapeutics Inc include director & President & CEO and Secretary Evert B. Schimmelpennink , Chief Financial Officer Daniel R. Chevallard , and Chief Commercial Officer Shawn Olsson .
LENZ Therapeutics Inc (LENZ) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in LENZ Therapeutics Inc (LENZ). Other recent insider transactions involving LENZ Therapeutics Inc (LENZ) include a net sale of 1,885,262 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 9,698 shares made by Daniel R. Chevallard , and a net purchase of 28,089 shares made by Evert B. Schimmelpennink .
In summary, during the past 3 months, insiders sold 0 shares of LENZ Therapeutics Inc (LENZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,895,262 shares of LENZ Therapeutics Inc (LENZ) were sold and 53,879 shares were bought by its insiders, resulting in a net sale of 1,841,383 shares.
LENZ Therapeutics Inc (LENZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
LENZ Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Artiva Biotherapeutics Inc do?
Who are the key executives at Artiva Biotherapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Artiva Biotherapeutics Inc. Other key executives at Artiva Biotherapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , SVP & Research and Development Heather Raymon , and director & President and CEO Fred Aslan .
Artiva Biotherapeutics Inc (ARTV) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Artiva Biotherapeutics Inc (ARTV). Other recent insider transactions involving Artiva Biotherapeutics Inc (ARTV) include a net purchase of 8,636,021 shares made by Ra Capital Healthcare Fund Lp , a net sale of 87,678 shares made by Fred Aslan , and a net purchase of 1,432,291 shares made by Gc Corp. .
In summary, during the past 3 months, insiders sold 53,040 shares of Artiva Biotherapeutics Inc (ARTV) in total and bought 2,125,605 shares, with a net purchase of 2,072,565 shares. During the past 18 months, 113,602 shares of Artiva Biotherapeutics Inc (ARTV) were sold and 10,068,312 shares were bought by its insiders, resulting in a net purchase of 9,954,710 shares.
Artiva Biotherapeutics Inc (ARTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Artiva Biotherapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Bicara Therapeutics Inc do?
Who are the key executives at Bicara Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Bicara Therapeutics Inc. Other key executives at Bicara Therapeutics Inc include Chief Financial Officer Ivan Hyep , President and COO Ryan Cohlhepp , and director & Chief Executive Officer Claire Mazumdar .
Bicara Therapeutics Inc (BCAX) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Bicara Therapeutics Inc (BCAX). Other recent insider transactions involving Bicara Therapeutics Inc (BCAX) include a net sale of 198,000 shares made by Ryan Cohlhepp , a net sale of 150,900 shares made by Ivan Hyep , and a net sale of 200,000 shares made by Claire Mazumdar .
In summary, during the past 3 months, insiders sold 144,700 shares of Bicara Therapeutics Inc (BCAX) in total and bought 0 shares, with a net sale of 144,700 shares. During the past 18 months, 754,011 shares of Bicara Therapeutics Inc (BCAX) were sold and 300,000 shares were bought by its insiders, resulting in a net sale of 454,011 shares.
Bicara Therapeutics Inc (BCAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicara Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Sionna Therapeutics Inc do?
Who are the key executives at Sionna Therapeutics Inc?
Peter Kolchinsky is the director & 10 percent owner of Sionna Therapeutics Inc. Other key executives at Sionna Therapeutics Inc include Chief Legal Officer Jennifer Fitzpatrick , 10 percent owner Tpg Gp A, Llc , and director & 10 percent owner Ra Capital Healthcare Fund Lp .
Sionna Therapeutics Inc (SION) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Sionna Therapeutics Inc (SION). Other recent insider transactions involving Sionna Therapeutics Inc (SION) include a net sale of 1,235,000 shares made by Orbimed Advisors Llc , a net sale of 1,235,000 shares made by Peter A. Thompson , and a net sale of 698,418 shares made by Bruce Booth .
In summary, during the past 3 months, insiders sold 413,976 shares of Sionna Therapeutics Inc (SION) in total and bought 0 shares, with a net sale of 413,976 shares. During the past 18 months, 4,284,695 shares of Sionna Therapeutics Inc (SION) were sold and 60,000 shares were bought by its insiders, resulting in a net sale of 4,224,695 shares.
Sionna Therapeutics Inc (SION)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sionna Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Evommune Inc do?
Who are the key executives at Evommune Inc?
Peter Kolchinsky is the director & 10 percent owner of Evommune Inc. Other key executives at Evommune Inc include Chief Financial Officer Kyle Carver , director & President & CEO Luis C. Pena , and EVP & Operations Janice Suzann Drew .
Evommune Inc (EVMN) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Evommune Inc (EVMN). Other recent insider transactions involving Evommune Inc (EVMN) include a net sale of 24,225 shares made by Luis C. Pena , a net sale of 18,175 shares made by Jeegar Pravinkumar Patel , and a net sale of 17,175 shares made by Kyle Carver .
In summary, during the past 3 months, insiders sold 100,854 shares of Evommune Inc (EVMN) in total and bought 11,000 shares, with a net sale of 89,854 shares. During the past 18 months, 100,854 shares of Evommune Inc (EVMN) were sold and 4,387,000 shares were bought by its insiders, resulting in a net purchase of 4,286,146 shares.
Evommune Inc (EVMN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evommune Inc Insider Transactions
- Download to Excel(.xlsx)
What does SpyGlass Pharma Inc do?
Who are the key executives at SpyGlass Pharma Inc?
Peter Kolchinsky is the director & 10 percent owner of SpyGlass Pharma Inc. Other key executives at SpyGlass Pharma Inc include 10 percent owner Edward T Mathers , Chief R&D Officer Chetan Pratap Pujara , and Chief Operating Officer Dennewill James Robert Jr. .
SpyGlass Pharma Inc (SGP) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in SpyGlass Pharma Inc (SGP). Other recent insider transactions involving SpyGlass Pharma Inc (SGP) include a net purchase of 3,690,000 shares made by Ra Capital Healthcare Fund Lp , a net purchase of 937,500 shares made by Ali Behbahani , and a net purchase of 937,500 shares made by Paul Edward Walker .
In summary, during the past 3 months, insiders sold 0 shares of SpyGlass Pharma Inc (SGP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SpyGlass Pharma Inc (SGP) were sold and 13,842,500 shares were bought by its insiders, resulting in a net purchase of 13,842,500 shares.
SpyGlass Pharma Inc (SGP)'s detailed insider trading history can be found in Insider Trading Tracker table.
SpyGlass Pharma Inc Insider Transactions
- Download to Excel(.xlsx)
What does Adicet Bio Inc do?
Who are the key executives at Adicet Bio Inc?
Peter Kolchinsky is the 10 percent owner of Adicet Bio Inc. Other key executives at Adicet Bio Inc include director & 10 percent owner Orbimed Advisors Llc , 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Ra Capital Management, L.p. .
Adicet Bio Inc (ACET) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Adicet Bio Inc (ACET). Other recent insider transactions involving Adicet Bio Inc (ACET) include a net purchase of 4,895,342 shares made by Orbimed Advisors Llc , and a net purchase of 223,596 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Adicet Bio Inc (ACET) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 104,658 shares of Adicet Bio Inc (ACET) were sold and 536,096 shares were bought by its insiders, resulting in a net purchase of 431,438 shares.
Adicet Bio Inc (ACET)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adicet Bio Inc Insider Transactions
- Download to Excel(.xlsx)
What does Parabilis Medicines Inc do?
Who are the key executives at Parabilis Medicines Inc?
Peter Kolchinsky is the director of Parabilis Medicines Inc. Other key executives at Parabilis Medicines Inc include 10 percent owner Soleus Capital, Llc , 10 percent owner Soleus Capital Master Fund, L.p. , and 10 percent owner Soleus Capital Group, Llc .
Parabilis Medicines Inc (PBLS) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Parabilis Medicines Inc (PBLS). Other recent insider transactions involving Parabilis Medicines Inc (PBLS) include a net purchase of 21,433,343 shares made by Ra Capital Healthcare Fund Lp , a net purchase of 30,000 shares made by Alan Sebulsky , and a net purchase of 500,000 shares made by Soleus Private Equity Fund Iii, L.p. .
In summary, during the past 3 months, insiders sold 0 shares of Parabilis Medicines Inc (PBLS) in total and bought 21,963,343 shares, with a net purchase of 21,963,343 shares. During the past 18 months, 0 shares of Parabilis Medicines Inc (PBLS) were sold and 21,963,343 shares were bought by its insiders, resulting in a net purchase of 21,963,343 shares.
Parabilis Medicines Inc (PBLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Parabilis Medicines Inc Insider Transactions
- Download to Excel(.xlsx)
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Peter Kolchinsky is the 10 percent owner of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include director & 10 percent owner Orbimed Genesis Gp Llc , director & 10 percent owner Orbimed Advisors Llc , and 10 percent owner Ra Capital Healthcare Fund Lp .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 832,021 shares made by Krishna Vaddi , a net purchase of 2,815,315 shares made by Orbimed Advisors Llc , and a net purchase of 2,815,315 shares made by David P Bonita .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prelude Therapeutics Inc (PRLD) were sold and 6,562,651 shares were bought by its insiders, resulting in a net purchase of 6,562,651 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
- Download to Excel(.xlsx)
What does Hemab Therapeutics Holdings Inc do?
Who are the key executives at Hemab Therapeutics Holdings Inc?
Peter Kolchinsky is the director & 10 percent owner of Hemab Therapeutics Holdings Inc. Other key executives at Hemab Therapeutics Holdings Inc include 10 percent owner Len Blavatnik , 10 percent owner Access Industries Holdings Llc , and 10 percent owner Access Industries Management, Llc .
Hemab Therapeutics Holdings Inc (COAG) Insider Trades Summary
Over the past 18 months, Peter Kolchinsky made no insider transaction in Hemab Therapeutics Holdings Inc (COAG). Other recent insider transactions involving Hemab Therapeutics Holdings Inc (COAG) include a net purchase of 2,970,541 shares made by Ra Capital Healthcare Fund Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Hemab Therapeutics Holdings Inc (COAG) in total and bought 72,467 shares, with a net purchase of 72,467 shares. During the past 18 months, 0 shares of Hemab Therapeutics Holdings Inc (COAG) were sold and 2,970,541 shares were bought by its insiders, resulting in a net purchase of 2,970,541 shares.
Hemab Therapeutics Holdings Inc (COAG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hemab Therapeutics Holdings Inc Insider Transactions
- Download to Excel(.xlsx)
Peter Kolchinsky Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Kolchinsky. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Peter Kolchinsky's mailing address is: Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
